News

The purpose of the Phase I trial of PW 4153 is to assess the bioavailability and pharmacokinetic blood levels of Penwest’s formulation of the drug in healthy volunteers.

Approval by the notified body for a CE Mark would allow CardioPass to be marketed and sold in all EU countries as well as other countries worldwide that

The new office is expected to allow MDS Pharma Services to better serve the Japanese pharmaceutical and biotechnology markets, and further enable growth opportunities both in Japan and

The Phase Ib clinical trial is designed to evaluate safety and to establish a maximum-tolerated dose of carfilzomib in combination with lenalidomide and dexamethasone on a 28 day

According to the new guidelines children as young as eight with LDL, or ‘bad’, cholesterol of 190mg per deciliter, or those with LDL of 160mg and a family

According to the survey, pharma companies are largely shifting away from selling medicines and are focusing on promoting health outcomes through initiatives like raising patients’ long-term use of

According to Michael Leavitt, secretary of the US Department of Health and Human Services (HHS), the regulatory agencies in the US, EU and Australia will jointly plan, allocate

The Bioheart 3370 heart failure monitor collects data from a range of vital sign monitoring devices, a weight scale and a voice-activated heart failure status questionnaire, and provides

The payment is made by the company’s co-development partner in Locteron, Biolex Therapeutics. The additional bridge financing will enable OctoPlus to secure one of the longer term financing